Skip to content
Search

Latest Stories

Submit Guest Post

Morningstar owner donates £500,000 to help Covid-19 victims in India

Morningstar owner donates £500,000 to help Covid-19 victims in India

A charity, founded by Morningstar Pharmaceuticals' owner Dr Nik Kotecha and his wife Moni, has donated half a million pounds to help hundreds of thousands of people impacted by the coronavirus pandemic in India.

Randal Charitable Foundation’s donation to the British Asian Trust’s Covid-19 Emergency Appeal helped saved over 137,000 lives with emergency kits between June and November 2020.


Facilitated by local non-governmental organisations - Goonj and Jan Sahas - the charity provided more than 27,500 families devastated by the impact of the pandemic across 15 Indian states with ration kits that included essentials like pulses, rice/flour, oil and vegetables.

"This is a good news story in the midst of this devastating virus with its unprecedented long-term effects on individuals, families and economies, said Richard Hawkes, chief executive of the British Asian Trust.

"The generosity of the Randal Charitable Foundation and dedication of its Founding Trustees Dr Nik and Moni Kotecha, together with the skills of our partners on the ground, shows what can be achieved at pace and through collaboration. This is a fantastic example of focused action by members of the British Asian community to support those most immediately in need. We are hugely grateful for the impact it has enabled."

Kotecha said: "We wanted to address the challenges in India as the early stages of the pandemic unfolded, with millions suddenly without jobs, security or any source of income.

"It is fantastic to have worked with our trusted partner the British Asian Trust and through amazing organisations on the ground, whose knowledge and experience ensures maximum impact in a crisis situation. We are delighted to have supported so many people."

Add EasternEye As Your Trusted Source
preferred source on google news

More For You

Migrants pay 60% more into NHS than their healthcare costs, analysis finds

The Immigration Health Surcharge is a fee that most people applying for eligible UK visas must pay as part of their immigration application. It is intended to contribute towards the cost of healthcare during their stay in the country.

Migrants pay 60% more into NHS than their healthcare costs, analysis finds

Highlights:

  • Migrants paying the IHS contributed at least 60% more to NHS finances than their estimated healthcare costs in 2023/24, including standard tax contributions.
  • The annual surcharge has risen from £200 to £1,035 for most visa applicants.
  • IHS revenue peaked at almost £2.5 billion in 2024/25.
  • The surcharge now accounts for more than 1 per cent of the NHS budget.
  • Revenue fell to £2.3 billion in 2025/26 as immigration numbers declined.
  • Around one-fifth of the NHS workforce comes from overseas, according to the Nuffield Trust fellow quoted in the report.

  • Migrants who pay to live and work in the UK are contributing substantially more to NHS finances than the estimated cost of the healthcare they receive, according to new analysis by the Nuffield Trust. The findings have reignited debate over immigration, healthcare funding and the purpose of the Immigration Health Surcharge (IHS).

    Keep ReadingShow less